BACKGROUND: Given observational findings that physical activity reduces breast cancer risk, improves survival, and improves quality of life in breast cancer survivors, a need has been identified for randomized controlled trials that test the efficacy of exercise on biological mechanisms associated with breast cancer survival. The primary aims of the Yale Exercise and Survivorship Study were to 1) determine the feasibility of recruiting breast cancer survivors into a randomized controlled trial of the effects of exercise on biological markers and/or mechanisms associated with survival, 2) compare the effectiveness of various recruitment strategies on accrual rates and baseline characteristics, and 3) report adherence to the exercise trial. METHODS:Seventy-five postmenopausal breast cancer survivors self-referred into the trial or were recruited through the New Haven Tumor [corrected] Registry and randomly assigned to an exercise (n = 37) or usual-care (n = 38) group. The exercise group participated in 150 min/wk of supervised gym-based and home-based aerobic exercise for 6 months. The usual-care group was instructed to maintain current physical activity level. RESULTS: A total of 75 women (an accrual rate of 9.5%) were randomized to the trial. Rates of accrual were higher for women who self-referred into the study (19.8%) compared with women recruited via the cancer registry (7.6%); however, demographic, physiologic, and prognostic characteristics did not differ between the 2 recruitment strategies. On average, exercisers increased moderate- intensity to vigorous-intensity aerobic exercise by 129 minutes per week compared with 44 minutes per week among usual-care participants (P < .001). Women in the exercise-intervention group increased their average pedometer steps by 1621 steps per day compared with a decrease of 60 steps per day among women in the usual-care group (P < .01). CONCLUSIONS: Findings from this study will provide useful information for investigators who are conducting exercise trials in cancer populations, clinicians who are treating women diagnosed with breast cancer, and exercise professionals who are developing community-based exercise programs for cancer survivors.
RCT Entities:
BACKGROUND: Given observational findings that physical activity reduces breast cancer risk, improves survival, and improves quality of life in breast cancer survivors, a need has been identified for randomized controlled trials that test the efficacy of exercise on biological mechanisms associated with breast cancer survival. The primary aims of the Yale Exercise and Survivorship Study were to 1) determine the feasibility of recruiting breast cancer survivors into a randomized controlled trial of the effects of exercise on biological markers and/or mechanisms associated with survival, 2) compare the effectiveness of various recruitment strategies on accrual rates and baseline characteristics, and 3) report adherence to the exercise trial. METHODS: Seventy-five postmenopausal breast cancer survivors self-referred into the trial or were recruited through the New Haven Tumor [corrected] Registry and randomly assigned to an exercise (n = 37) or usual-care (n = 38) group. The exercise group participated in 150 min/wk of supervised gym-based and home-based aerobic exercise for 6 months. The usual-care group was instructed to maintain current physical activity level. RESULTS: A total of 75 women (an accrual rate of 9.5%) were randomized to the trial. Rates of accrual were higher for women who self-referred into the study (19.8%) compared with women recruited via the cancer registry (7.6%); however, demographic, physiologic, and prognostic characteristics did not differ between the 2 recruitment strategies. On average, exercisers increased moderate- intensity to vigorous-intensity aerobic exercise by 129 minutes per week compared with 44 minutes per week among usual-care participants (P < .001). Women in the exercise-intervention group increased their average pedometer steps by 1621 steps per day compared with a decrease of 60 steps per day among women in the usual-care group (P < .01). CONCLUSIONS: Findings from this study will provide useful information for investigators who are conducting exercise trials in cancer populations, clinicians who are treating women diagnosed with breast cancer, and exercise professionals who are developing community-based exercise programs for cancer survivors.
Authors: Laura Lewis Frank; Bess E Sorensen; Yutaka Yasui; Shelley S Tworoger; Robert S Schwartz; Cornelia M Ulrich; Melinda L Irwin; Rebecca E Rudolph; Kumar B Rajan; Frank Stanczyk; Deborah Bowen; David S Weigle; John D Potter; Anne McTiernan Journal: Obes Res Date: 2005-03
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Isaac M Lipkus; David Lobach; Denise Clutter Snyder; Richard Sloane; Bercedis Peterson; Jennifer M Macri; Cheryl L Rock; Colleen M McBride; William E Kraus Journal: J Clin Oncol Date: 2007-07-01 Impact factor: 44.544
Authors: Rebecca M Speck; Kerry S Courneya; Louise C Mâsse; Sue Duval; Kathryn H Schmitz Journal: J Cancer Surviv Date: 2010-01-06 Impact factor: 4.442
Authors: S Casla; P Hojman; I Márquez-Rodas; S López-Tarruella; Y Jerez; R Barakat; M Martín Journal: Clin Transl Oncol Date: 2014-06-04 Impact factor: 3.405
Authors: Melinda L Irwin; Brenda Cartmel; Maura Harrigan; Fangyong Li; Tara Sanft; Laura Shockro; Keelin O'Connor; Nancy Campbell; Sara M Tolaney; Erica L Mayer; Rachel Yung; Rachel A Freedman; Ann H Partridge; Jennifer A Ligibel Journal: Cancer Date: 2016-11-28 Impact factor: 6.860
Authors: Amy M Berkman; Amy Trentham-Dietz; Kim Dittus; Vicki Hart; Christine M Vatovec; John G King; Ted A James; Susan G Lakoski; Brian L Sprague Journal: Prev Med Date: 2015-04-06 Impact factor: 4.018
Authors: F Hausmann; V V Iversen; M Kristoffersen; H Gundersen; E Johannsson; M Vika Journal: Support Care Cancer Date: 2018-04-14 Impact factor: 3.603
Authors: Melinda L Irwin; Marty Alvarez-Reeves; Lisa Cadmus; Eileen Mierzejewski; Susan T Mayne; Herbert Yu; Gina G Chung; Beth Jones; M Tish Knobf; Loretta DiPietro Journal: Obesity (Silver Spring) Date: 2009-02-19 Impact factor: 5.002
Authors: Sara B Jones; Gwendolyn A Thomas; Sara D Hesselsweet; Marty Alvarez-Reeves; Herbert Yu; Melinda L Irwin Journal: Cancer Prev Res (Phila) Date: 2012-12-04